H. Seo

发表

Immune checkpoint inhibitors for urothelial carcinoma

H. S. Kim, H. Seo, Hyung Suk Kim, 2018, Investigative and clinical urology.

Incidental prostate cancer detected by cystoprostatectomy in Korean men.

Seung Ok Yang, W. Park, H. Seo, 2009, Urology.

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy

J. Joo, W. Park, H. Seo, 2016, PloS one.

The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up

J. Oh, K. Joo, B. Jeong, 2021, Frontiers in Oncology.

Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction

J. Joo, H. Seo, K. Lee, 2017, PloS one.

Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine

H. Seo, K. Lee, J. Joung, 2017, BioMed research international.

Primary renal myxofibrosarcoma in a woman: A case report and literaturereview

W. Park, H. Seo, Sung‐Han Kim, 2017 .

Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer

W. Park, H. Seo, K. Lee, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study

Choung-Soo Kim, H. Seo, K. Lee, 2019, Investigative and clinical urology.

The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression

H. Seo, Kyung-cHAe Jeong, Sang-Jin Lee, 2016, Oncotarget.

Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology

H. Seo, H. Lee, H. Choi, 2021, Biomedicines.

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy

W. Park, H. Seo, K. Lee, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Pretreatment Prognostic Nutritional Index Is an Independent Predictor of Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy

Sohee Kim, H. Seo, K. Lee, 2017, Clinical genitourinary cancer.

Usefulness of the mass screening program for colorectal cancer in China: further long-term validation is needed to confirm its value

H. Seo, W. Kwon, 2020, Annals of translational medicine.

Clinical Implication of Preoperative Renal Function on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy

Tae Heon Kim, J. Oh, J. Ku, 2022, Biomedicines.

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching

J. Joo, H. Seo, K. Lee, 2018, BioMed research international.

Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer

W. Park, B. Nam, H. Seo, 2015, PloS one.

Enhanced Recovery After Surgery Program for Radical Cystectomy

H. Seo, W. Kwon, 2022, The Korean Journal of Urological Oncology.

Docetaxel Chemotherapy of Korean Patients with Hormone-refractory Prostate Cancer : Comparative Analysis between 1st-line and 2nd-line Docetaxel

Seung Ok Yang, K. Cho, H. Seo, 2008, Yonsei medical journal.

Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy

J. Joo, H. Seo, K. Lee, 2017, Oncotarget.

Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum‐based regimens

W. Park, Sohee Park, H. Seo, 2011, International journal of urology : official journal of the Japanese Urological Association.

Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract

K. Cho, H. Seo, K. Lee, 2011, Cancer Chemotherapy and Pharmacology.

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

H. Seo, K. Han, I. Jeong, 2007, British Journal of Cancer.

Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens

W. Park, H. Seo, K. Lee, 2011, Journal of Korean medical science.

Urinary Biomarker in Bladder Cancer at Present Time

H. Seo, Sung Han Kim, H. Lee, 2020, The Korean Journal of Urological Oncology.

Overestimation of nuclear matrix protein 22 in concentrated urine.

Sohee Park, H. Seo, K. Lee, 2013, Urology.

Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.

Seung Ok Yang, W. Park, H. Seo, 2007, Urology.

Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea

Hyunsoon Cho, W. Park, H. Seo, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer

H. Seo, W. Kwon, 2022, The Korean Journal of Urological Oncology.

Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer

H. S. Kim, H. Seo, 2021, Investigative and clinical urology.

Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.

H. Seo, K. Lee, S. Ryu, 2007, Urology.

Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer

H. Seo, W. Kwon, 2020, Translational cancer research.

Familial Prostate Cancer in Three Brothers

W. Park, K. Cho, H. Seo, 2009 .

Case Report: Good responsiveness of metastatic sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation to immune checkpoint inhibitor after radical surgery and chemotherapy

W. Park, H. Seo, Sung Han Kim, 2022, F1000Research.

Clinical Value of PTEN in Patients with Superficial Bladder Cancer

Seung Ok Yang, W. Park, H. Seo, 2008, Urologia Internationalis.

Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.

W. Park, H. Seo, In-Hoo Kim, 2014, The Journal of urology.

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.

D. Bajorin, H. Nishiyama, A. Balar, 2021, The Lancet. Oncology.

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

J. Joo, Sohee Kim, H. Seo, 2016, BMC Cancer.

Optimizing frontline therapy in advanced urothelial cancer

H. Seo, W. Kwon, 2020, Translational andrology and urology.

Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea

J. Shim, J. Ku, B. Jeong, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer

W. Park, H. Seo, K. Lee, 2015, BMC Urology.

938 LOCALIZATION OF PROSTATE CANCER: A PROSPECTIVE INTRA-PATIENT COMPARISON STUDY OF MR IMAGING, FLUORINE 18-FLUORODEOXYGLUCOSE PET/CT AND CARBON 11-ACETATE PET/CT

W. Park, H. Seo, K. Han, 2009 .

Hand-Holding during Cystoscopy Decreases Patient Anxiety, Pain, and Dissatisfaction: A Pilot Randomized Controlled Trial

H. Seo, H. Jeong, I. Seo, 2017, Urologia Internationalis.

Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer

Ji-Sun Shin, W. Park, H. Seo, 2014, Oncotarget.

Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study

H. Seo, Sokbom Kang, S. Seo, 2022, BMC Cancer.

Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder

H. Seo, H. Lee, 2022, Investigative and clinical urology.

Chapter 20 – Immunotherapy: Bacille Calmette–Guérin

H. Seo, Sung Han Kim, 2018 .

Single-Center Analysis of Human Papillomavirus Infection and P16INK4A Expression among Korean Patients with Penile Cancer

W. Park, H. Seo, K. Lee, 2019, BioMed research international.

Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)

D. Bajorin, A. Balar, A. Kamat, 2020 .

Docetaxel‐resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1

H. Seo, Kyung-cHAe Jeong, Sang-Jin Lee, 2020, The Prostate.

The Retrospective Analysis of Prognostic Significance of Smoking Status in Bladder Cancer

W. Park, Sohee Kim, H. Seo, 2017 .

Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy

H. Seo, Sokbom Kang, S. Seo, 2012, International Urogynecology Journal.

Case Report: Good responsiveness of metastatic sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation to immune checkpoint inhibitor after radical surgery and adjuvant chemotherapy

W. Park, H. Seo, Sung Han Kim, 2020 .

J. Joo, W. Park, Sohee Kim, 2017, Oncotarget.

Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea

Hee Chul Shin, J. Joo, H. S. Kim, 2015, Journal of Korean medical science.

A prospective evaluation of conventional cystography for detection of urine leakage at the vesicourethral anastomosis site after radical prostatectomy based on computed tomography.

K. Han, H. Seo, J. Joung, 2011, Clinical radiology.

The outcome with ureteric stents for managing non‐urological malignant ureteric obstruction

K. Han, H. Seo, I. Jeong, 2007, BJU international.

Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma

H. Seo, K. Lee, M. Song, 2019, Investigative and clinical urology.

Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy

J. Joo, W. Park, H. Seo, 2016, Histopathology.

Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment

H. Seo, H. Lee, 2021, International journal of molecular sciences.

Evaluation of the Efficacy of Solifenacin for Preventing Catheter‐Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non‐Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study

J. Joo, Sohee Kim, H. Seo, 2017, Clinical genitourinary cancer.

Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis.

W. Park, K. Cho, H. Seo, 2010, Cancer research and treatment : official journal of Korean Cancer Association.

Epidermal Growth Factor Receptor as Predicting Factor on Biochemical Recurrence after Radical Prostatectomy: A Prospective Study

Eunkyoung Kim, J. W. Lee, W. Park, 2008 .

Genetic Variations of α-Methylacyl-CoA Racemase Are Associated with Sporadic Prostate Cancer Risk in Ethnically Homogenous Koreans

W. Park, Sohee Park, Yeon-Su Lee, 2013, BioMed research international.

Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer

W. Park, H. Seo, K. Lee, 2018, Oncotarget.

The Quantified Level of Circulating Prostate Stem Cell Antigen mRNA relative to GAPDH Level Is a Clinically Significant Indictor for Predicting Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy

W. Park, H. Seo, K. Lee, 2015, BioMed research international.

Haplotype analysis of prostate stem cell antigen and association with prostate cancer risk.

W. Park, Sohee Park, Yeon-Su Lee, 2011, The Journal of urology.

Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high‐risk prostate cancer

W. Park, K. Cho, H. Seo, 2010, Journal of surgical oncology.

Reverse transcriptase‐polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: Potential value in molecular staging of prostate cancer

Seung Ok Yang, W. Park, H. Seo, 2007, International journal of urology : official journal of the Japanese Urological Association.

Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study

H. S. Kim, J. Ku, I. H. Chang, 2020, Frontiers in Oncology.

Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray

W. Park, H. Seo, K. Lee, 2019, Cancer research and treatment : official journal of Korean Cancer Association.

Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter

H. Seo, In-Hoo Kim, Sang-Jin Lee, 2014, Oncotarget.

P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model

B. H. Chi, I. H. Chang, H. Seo, 2015, Journal of Korean medical science.

Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations

Lan N. Nguyen, H. Seo, H. Lee, 2023, Cancers.

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

H. Seo, Sung Han Kim, W. Kwon, 2018 .

Prostatectomy Provides Better Symptom-Free Survival Than Radiotherapy Among Patients With High-Risk or Locally Advanced Prostate Cancer After Neoadjuvant Hormonal Therapy

W. Park, H. Seo, Sung‐Han Kim, 2018, The Korean Journal of Urological Oncology.

The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients

Sohee Kim, H. Seo, K. Lee, 2018, Japanese journal of clinical oncology.

Pembrolizumab (pembro) for the treatment of patients with Bacillus Calmette-Guérin (BCG) unresponsive, high-risk (HR) non–muscle-invasive bladder cancer (NMIBC): Over two years follow-up of KEYNOTE-057.

D. Bajorin, H. Nishiyama, A. Balar, 2020 .

Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study

W. Park, H. Seo, H. Lee, 2022, The Journal of urology.

Pelvic floor musculature and bladder neck changes before and after continence recovery after radical prostatectomy in pelvic MRI

H. Seo, K. Lee, D. Sohn, 2014, Journal of magnetic resonance imaging : JMRI.

Correlation Analyses of Computed Tomography and Magnetic Resonance Imaging for Calculation of Prostate Volume in Colorectal Cancer Patients with Voiding Problems Who Cannot Have Transrectal Ultrasonography

H. Seo, K. Lee, Boram Park, 2019, BioMed research international.

Emerging agents for the treatment of metastatic urothelial cancer

H. Seo, W. Kwon, 2021, Investigative and clinical urology.

Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study

H. Seo, K. Lee, J. Joung, 2020, Investigative and clinical urology.

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis

J. Joo, H. Seo, K. Lee, 2019, BMC Cancer.

Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy

J. Joo, H. Seo, K. Lee, 2019, PloS one.

Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG).

D. Bajorin, H. Nishiyama, A. Balar, 2019, Journal of Clinical Oncology.

Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation

W. Park, H. Seo, K. Lee, 2014, PloS one.

The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer

H. Seo, J. Joung, Sung Han Kim, 2021 .

J. Joo, Sohee Kim, H. Seo, 2016, BMC Cancer.

Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review

W. Park, H. Seo, K. Lee, 2016, World Journal of Surgical Oncology.

Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib

B. Nam, H. Seo, K. Lee, 2013, Annals of Surgical Oncology.

De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors

H. Seo, Sung Han Kim, E. Park, 2022, The Korean Journal of Urological Oncology.

PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study

J. Joo, W. Park, H. Seo, 2016, Asian journal of andrology.

The Correlation of Tissue-Based Biomarkers in Primary and Metastatic Renal Cell Carcinoma Lesions: A Tissue Microarray Study

J. Joo, W. Park, H. Seo, 2016 .

Clear cell papillary renal cell carcinoma: A case report and review of the literature

H. Seo, K. Lee, J. Joung, 2018, World journal of nephrology.

Establishment and application of bladder cancer patient-derived xenografts as a novel preclinical platform

H. Seo, Sang-Jin Lee, Y. Suh, 2017 .

Pretreatment assessment of tumor enhancement on contrast‐enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy

M. Jeong, K. Cho, H. Seo, 2010, Cancer.

Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity

H. Seo, Yuh-Seog Jung, Hyo-Kyung Han, 2017, Drug delivery.

Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea

W. Park, H. Seo, K. Jung, 2018, BMC Cancer.

Urinary Diversion: Ileal Conduit to Orthotopic Neobladder Substitution

H. Seo, M. Chung, 2007 .

Analysis of Changes in the Total Lymphocyte and Eosinophil Count during Immunotherapy for Metastatic Renal Cell Carcinoma: Correlation with Response and Survival

Seung Ok Yang, Seung-sik Hwang, H. Seo, 2007, Journal of Korean medical science.

A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy

J. Joo, H. Seo, K. Lee, 2017, Oncotarget.

The efficacy of transureteroureterostomy for ureteral reconstruction during surgery for a non‐urologic pelvic malignancy

H. Seo, K. Lee, I. Jeong, 2008, Journal of surgical oncology.

Changes in Urination According to the Sound of Running Water Using a Mobile Phone Application

Sohee Kim, H. Seo, K. Lee, 2015, PloS one.

Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer

J. Oh, H. Seo, J. H. Hyun, 2015, Annals of surgical treatment and research.

A Case Report of Partial Nephrectomy of Mucinous Cystadenocarcinoma in Kidney and Its Literature Review

W. Park, H. Seo, K. Lee, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma

W. Park, H. Seo, K. Lee, 2017, PloS one.

Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.

J. Ro, W. Park, K. Cho, 2009, The Journal of urology.

Prognostic value of p53 and Ki-67 expression in intermediate-risk patients with nonmuscle-invasive bladder cancer receiving adjuvant intravesical mitomycin C therapy.

W. Park, K. Cho, H. Seo, 2010, Urology.

Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study

Hyunsoon Cho, W. Park, H. Seo, 2015, PloS one.

Lifestyle Risk Prediction Model for Prostate Cancer in a Korean Population

Sohee Kim, B. Nam, H. Seo, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study

W. Park, H. Seo, K. Jung, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study

H. Seo, K. Lee, J. Joung, 2016, BioMed research international.

The Comparison of Oncologic Outcomes between Open and Laparoscopic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Korean Multicenter Collaborative Study

Tae Heon Kim, J. Ku, B. Jeong, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

The Effect of the First Computed Tomography Examination on Renal Function During the Initial Cancer Work-up in Newly Diagnosed Cancer Patients without Chronic/Kidney Disease: A Retrospective, Single-institution, Observational Study

H. Seo, Sung‐Han Kim, K. Lee, 2018 .

The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry

J. Joo, W. Park, H. Seo, 2017, PloS one.

Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer

H. Seo, K. Lee, J. Joung, 2008, Journal of Korean medical science.

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies

H. Seo, H. Ha, H. Lee, 2023, Investigative and clinical urology.

Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer

W. Park, H. Seo, K. Lee, 2021, Frontiers in Oncology.

Developing a prediction model for disease‐free survival from upper urinary tract urothelial carcinoma in the Korean population

B. Jeong, H. Seo, M. Song, 2019, Cancer medicine.

Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder

H. Seo, H. Lee, Young-Ju Kwon, 2022, Biomedicines.

Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea

W. Park, H. Seo, K. Jung, 2018, BMC Cancer.

Adjuvant intravesical instillation for primary T1G3 bladder cancer: BCG versus MMC in Korea.

W. Park, H. Seo, K. Lee, 2012, Anticancer research.

Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway

B. H. Chi, I. H. Chang, H. Seo, 2014, Journal of Korean medical science.

A retrospective multicenter comparison of conditional cancer-specific survival between laparoscopic and open radical nephroureterectomy in locally advanced upper tract urothelial carcinoma

J. Ku, B. Jeong, H. Seo, 2021, PloS one.

Identification of Immunohistochemical Factors That Predict the Synchronous or Metachronous Development of Bladder Tumors in Patients with Upper Urinary Tract Tumors

Seung Ok Yang, W. Park, H. Seo, 2008, Urologia Internationalis.

D. Bajorin, H. Nishiyama, A. Balar, 2019, Annals of Oncology.

Pembrolizumab for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG): Phase II KEYNOTE-057 trial.

D. Bajorin, A. Balar, A. Kamat, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Late Solitary Acrometastasis of the Hands as Unusual Metastatic Site ofRenal Cell Carcinoma: A Case Report and Literature Review

W. Park, H. Seo, Sung‐Han Kim, 2015 .

Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis

H. Seo, K. Lee, J. Joung, 2018, Scientific Reports.

Prostate Specific Membrane Antigen mRNA in Blood as a Potential Predictor of Biochemical Recurrence after Radical Prostatectomy

W. Park, K. Cho, H. Seo, 2010, Journal of Korean medical science.

Pembrolizumab for the treatment of patients with high-risk (HR) non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin: Extended follow-up of KEYNOTE-057 cohort A.

D. Bajorin, H. Nishiyama, A. Balar, 2021 .

Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients

W. Park, H. Seo, K. Lee, 2015, Prostate international.

Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: the referral cancer center experience and review of the literature.

K. Cho, H. Seo, K. Lee, 2008, Journal of endourology.

Partial Nephrectomy using Parenchymal Compression without Renal Pedicle Clamping

Seung Ok Yang, W. Park, H. Seo, 2007 .

Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin (BCG): Updated follow-up from KEYNOTE-057.

D. Bajorin, H. Nishiyama, A. Balar, 2019, Journal of Clinical Oncology.

The effect of predisposing atheroembolic risk factors on renal functional recovery between laparoscopy and open technique in patients with T1-stage renal cell carcinoma who underwent partial nephrectomy: a retrospective comparison study

H. Seo, K. Lee, J. Joung, 2017, Japanese journal of clinical oncology.

A Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic Thrombocytopenia

W. Park, H. Seo, K. Lee, 2018, Case Reports in Urology.

Treatment outcome of docetaxel plus prednisolone for metastatic castration-resistant prostate cancer in Korea.

W. Park, H. Seo, K. Lee, 2014, Journal of cancer research and therapeutics.

Association of common variations of 8q24 with the risk of prostate cancer in Koreans and a review of the Asian population

Jeongseon Kim, W. Park, Sohee Park, 2012, BJU international.

Genetic Polymorphism of Nerve Injury-induced Protein 1 in ProstateCancer

Jeongseon Kim, W. Park, A. Shin, 2016 .

Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis

J. Ku, B. Jeong, H. Seo, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Lymphatic Embolization versus Sclerotherapy for Symptomatic Post-operative Pelvic Lymphocele (LESPOL): A Randomized Pilot Study

J. Shin, C. Kwak, H. Seo, 2023, SN Comprehensive Clinical Medicine.

Retrospective analysis of 25 immunohistochemical tissue markers for differentiating multilocular cystic renal neoplasm of low malignant potential and multicystic renal cell carcinoma.

J. Joo, W. Park, H. Seo, 2018, Histology and histopathology.

Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high‐risk prostate cancer

W. Park, K. Cho, H. Seo, 2010, Journal of surgical oncology.